FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Advanced Pharma HEPERAIN 50 mg/50 mL Recall

HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0

Advanced Pharma Inc. · Houston, TX

Risk level
Class II
Reported by FDA
Jan 30, 2019
Recall ID
D-0430-2019
Check your lot numberHow we source this data

Summary

Advanced Pharma recalled HEPERAIN 50 mg/50 mL starting Jan 15, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0430-2019 on Jan 30, 2019. Reason: Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL). Status: Terminated.

Why it was recalled

Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)

Product description

HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Heparin 50 Units 50 mL, Sterile single use syringe, Avella of Houston an FDA Registered 503B Outsourcing Facility 9265 Kirby Dr. Houston, TX 77054 (877) 794-0404 ---- NDC: 42852-725-65

Lot numbers, UPCs & expiration codes

Lot: 12/19/18 0242 72565S BUD: 3/31/19

Where it was sold

TX, WA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0430-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 15, 2019
FDA report date
Jan 30, 2019
Quantity
160 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Advanced Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0430-2019, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Terminated
Country
United States
Event ID
81941
Address
9265 Kirby Dr
Code information
Lot: 12/19/18 0242 72565S BUD: 3/31/19
Postal code
77054-2520
Report date
Jan 30, 2019
Product type
Drugs
Recall number
D-0430-2019
Classification
Class II
Recalling firm
Advanced Pharma Inc.
Product quantity
160 syringes
Termination date
May 1, 2019
Reason for recall
Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)
Voluntary / mandated
Voluntary: Firm initiated
Product description
HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Heparin 50 Units 50 mL, Sterile single use syringe, Avella of Houston an FDA Registered 503B Outsourcing Facility 9265 Kirby Dr. Houston, TX 77054 (877) 794-0404 ---- NDC: 42852-725-65
Distribution pattern
TX, WA
Recall initiation date
Jan 15, 2019
Initial firm notification
Telephone
Center classification date
Feb 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0430-2019, published Jan 30, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls